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Purpose: We have previously identified specific epithelial proteins with altered expression in human diabetic central
corneas. Decreased hepatocyte growth factor receptor (c-met) and increased proteinases were functionally implicated in
the changes of these proteins in diabetes. The present study examined whether limbal stem cell marker patterns were
altered in diabetic corneas and whether c-met gene overexpression could normalize these patterns.
Methods: Cryostat sections of 28 ex vivo and 26 organ-cultured autopsy human normal and diabetic corneas were
examined by immunohistochemistry using antibodies to putative limbal stem cell markers including ATP-binding cassette
sub-family G member 2 (ABCG2), N-cadherin, ΔNp63α, tenascin-C, laminin γ3 chain, keratins (K) K15, K17, K19, β1
integrin, vimentin, frizzled 7, and fibronectin. Organ-cultured diabetic corneas were studied upon transduction with
adenovirus harboring c-met gene.
Results: Immunostaining for ABCG2, N-cadherin, ΔNp63α, K15, K17, K19, and β1 integrin, was significantly decreased
in the stem cell-harboring diabetic limbal basal epithelium either by intensity or the number of positive cells. Basement
membrane components, laminin γ3 chain, and fibronectin (but not tenascin-C) also showed a significant reduction in the
ex vivo diabetic limbus. c-Met gene transduction, which normalizes diabetic marker expression and epithelial wound
healing, was accompanied by increased limbal epithelial staining for K17, K19, ΔNp63α, and a diabetic marker α3β1
integrin, compared to vector-transduced corneas.
Conclusions: The data suggest that limbal stem cell compartment is altered in long-term diabetes. Gene therapy, such as
with c-met overexpression, could be able to restore normal function to diabetic corneal epithelial stem cells.
In pathological conditions, such as diabetes mellitus, the
cornea  is  significantly  affected  and  this  can  cause  visual
impairment. The most recognized diabetic complications in
the cornea include neurotrophic corneal ulcers, filamentous
keratitis,  loss  of  corneal  sensation,  and  a  characteristic
epithelial keratodystrophy, which is referred to as diabetic
keratopathy  [1-9].  Diabetic  cornea  exhibits  basement
membrane  abnormalities,  reduced  numbers  of
hemidesmosomes,  altered  growth  factor  content  and
signaling, epithelial cellular enlargement, edema, and delayed
wound healing resulting in persistent epithelial defects [2-4,
8-11].  Treatment  for  diabetic  keratopathy  remains
symptomatic [2].
Corneal  epithelial  renewal  and  healing  of  epithelial
wounds largely depend on corneal stem cells that, at least in
humans, reside in the basal epithelial layer of the corneoscleral
junction, limbus [12-21]. These cells represent less than 10%
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of the total limbal basal epithelial cell population [22,23].
Deficiencies of or damage to these limbal epithelial stem cells
(LESC) have serious implications for corneal function such
as in-growth of conjunctival cells and neovascularization of
the corneal stroma, which eventually lead to corneal opacity
and vision loss [20,24-26]. These cells have a high capacity
for self-renewal, which is retained throughout life. Corneal
maintenance  depends  on  LESC  as  a  source  of  epithelial
proliferation  and  rapid  renewal  through  generation  of
transient amplifying (TA) cells, which in turn differentiate
into epithelial cells during their centripetal movement [21,
27-29].
Because  of  its  role  in  epithelial  renewal  and  wound
healing, deficiency of the limbal niche and its residing LESC
may  be  responsible  for  abnormalities  in  diabetic  corneal
epithelium. In the present paper we examined various putative
stem cell markers in ex vivo diabetic and normal epithelial
limbal compartment, as well as in organ-cultured diabetic
corneas upon overexpression of c-met proto-oncogene shown
to  normalize  wound  healing  time  and  epithelial  marker
expression [30]. Immunostaining patterns of several putative
stem cell markers were altered in the diabetic limbus, and
some  of  these  patterns  could  be  normalized  by  c-met
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TABLE 1. DONOR CHARACTERISTICS.
Case number Diabetes type Age, sex Diabetes duration, years Cause of death
Ex vivo normal
95–12 - 17, F - gunshot wound
95–15 - 59, M - cardiac arrest
95–44 - 68, M - massive hemorrhage
99–19 - 79, F - respiratory arrest
99–61 - 80, F - myocardial infarction
03–3 - 71, M - myocardial infarction
03–09 - 72, M - lung cancer
05–16 - 56, M - ruptured aortic dissection
05–25 - 60, F - COPD
05–26 - 60, F - COPD
05–45 - 10, M - exsanguination
05–46 - 10, M - exsanguination
05–56 - 45, M cardiovascular accident
05–60 - 65, F - pneumonia
10–03 - 69, M - respiratory failure
Ex vivo diabetic
95–17 IDDM 79, M 5 cardiac arrest
95–18 IDDM 79, M 5 cardiac arrest
96–06 IDDM 69, M 22 acute cardiac event
96–30 NIDDM 77, F >5 cardiorespiratory arrest
96–46 IDDM, PDR 68, F >48 cardiorespiratory arrest
96–47 IDDM, PDR 68, F >48 cardiorespiratory arrest
96–95 IDDM 63, M 3 cardiovascular accident
96–96 IDDM 63, M 3 cardiovascular accident
99–08 IDDM, DR 67, F 30 myocardial infarction
99–79 IDDM, PDR 77, F unknown cardiac arrest
99–80 IDDM, PDR 77, F unknown cardiac arrest
01–47 IDDM, DR 64, F unknown ventricular arrhythmia
06–26 NIDDM 77, M 15 intracerebral hemorrhage
Organ-cultured diabetic
07–27 IDDM 81, M >10 acute renal failure
07–32 NIDDM 84, M 20 stroke
07–34 IDDM, DR 37, M 22 intracranial hemorrhage
08–35 IDDM, DR 88, M 38 cardiac arrest
08–36 NIDDM 82, M 15 stroke
08–38 IDDM 73 F >10 diabetic ketoacidosis
08–40 NIDDM 59, M 20 cardiac arrest
08–44 IDDM, DR 71, M 15 cardiopulmonary arrest
08–49 NIDDM 59, F 28 intracranial hemorrhage
08–54 NIDDM 57, M 10 myocardial infarction
08–57 IDDM 78, F 15 respiratory failure
09–12 NIDDM, DR 61, F unknown myocardial infarction
09–16 NIDDM 61, F >10 congestive heart failure
         M, male; F, female; PDR, proliferative diabetic retinopathy; COPD, chronic obstructive pulmonary disease. In the ex vivo
         groups, each case number refers to one cornea; in organ-cultured diabetic group, each case number refers to a pair of fellow
         corneas.overexpression. The data suggest that limbal compartment
may play an important role in diabetic corneal alterations that
can be corrected by gene therapy.
METHODS
Tissues:  Age-matched  normal,  diabetic  (with  insulin-
dependent  [IDDM]  or  non-insulin-dependent  [NIDDM]
diabetes),  and  diabetic  retinopathy  (DR)  autopsy  human
corneas were obtained from the National Disease Research
Interchange (NDRI, Philadelphia, PA), within 24 (for ex vivo)
to  48  h  after  death.  NDRI  has  a  human  tissue  collection
protocol approved by a managerial committee and subject to
National Institutes of Health oversight. In this study (Table
1), 15 normal (from 13 donors, mean age 57.8±21.8 years)
and 13 diabetic (from 9 donors; mean age 71.2±6.3 years; 7
with IDDM, 2 with NIDDM, 4 with DR) ex vivo corneas, as
well as 13 pairs of organ-cultured diabetic corneas (from 13
donors; mean age 68.5±14.4 years; 6 with IDDM, 7 with
NIDDM, 4 with DR) were used. Mean ages in all groups as
well as mean disease durations for known cases in ex vivo and
organ culture diabetic groups did not differ significantly. The
corneas  were  embedded  in  Optimal  Cutting  Temperature
(OCT) compound (Sakura Finetek USA, Inc., Torrance, CA)
and  stored  at  –80  °C  for  immunohistochemistry,  or  were
processed for organ culture.
Corneal organ culture and viral transduction: As described
previously [30,31], after filling the corneal concavity with
warm agar-collagen mixture, corneas were cultured in serum-
free medium with insulin-transferrin-selenite, antibiotics and
antimycotic  (Invitrogen,  Carlsbad,  CA),  at  a  liquid-air
interface  with  epithelium  facing  upwards.  Organ-cultured
diabetic corneas were transduced for 48 h with 1.0–2.0×108
plaque-forming units of recombinant adenoviruses, rAV-cmet
(harboring  full-length  c-met  open  reading  frame)  and  the
fellow  corneas  with  rAV-vector  (no  gene  inserted)  as  a
control.  Seventy-five  μg/ml  of  sterile  sildenafil  citrate
(Viagra®; Pfizer Corp., New York, NY) was added to the
culture  medium  along  with  the  viruses  to  increase  rAV
transduction efficiency [31]. Some transduced corneas were
processed  after  7–10  days  in  culture,  some  after  wound
healing experiments [30]. They were embedded in OCT and
5 μm cryostat sections cut for immunostaining on a Leica
CM1850 cryostat (McBain Instruments, Chatsworth, CA).
Immunohistochemistry:  The  list  of  primary  antibodies  to
putative stem cell markers is presented in Table 2. Different
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TABLE 2. ANTIBODIES USED IN THE STUDY.
Antigen Antibody Source Dilution Immunostaining
ABCG2 Mouse mAb MAB4155 Millipore 1:50 -
ABCG2 Mouse mAb sc-58222 Santa Cruz Biotechnology 1:5 +
ABCG2 Rabbit pAb sc-25821 Santa Cruz Biotechnology 1:20 +
C/EBPδ Rabbit pAb sc-636 Santa Cruz Biotechnology 1:20 -
Fibronectin Mouse mAb 568 [72] 1:60 +
Integrin β1 Mouse mAb MAB1959 Millipore 1:50 +
Integrin β1 Mouse mAb MAB2000 Millipore 1:50 +
Keratin 15 Mouse mAb sc-47697 Santa Cruz Biotechnology 1:10 +
Keratin 17 Mouse mAb E3 [73] straight +
Keratin 17 Rabbit mAb #4543 Cell Signaling 1:50 +
Keratin 19 Mouse mAb MAB1607 Millipore 1:10 +
Keratin 19 Mouse mAb MA1–35554 Thermo Scientific 1:10 +
Keratin 19 Rabbit pAb PA1–38014 Thermo Scientific 1:20 +
Keratin 19 Mouse mAb MAB1608 Millipore 1:10 +
Laminin β1 Rat mAb LT3 [74] straight +
Laminin β2 Mouse mAb C4 Developmental Hybridoma Bank straight +
Laminin γ1 Rat mAb A5 [75] straight +
Laminin γ3 Rabbit pAb R96 [76] 1:500 +
Laminin γ3 Rabbit pAb sc-25719 Santa Cruz Biotechnology 1:20 -
Laminin γ3 Goat pAb sc-16601 Santa Cruz Biotechnology 1:10 +
N-Cadherin Mouse mAb 3B9 Invitrogen 1:20 +
N-Cadherin Rabbit pAb 12221 Abcam 1:50 -
N-Cadherin Rabbit pAb sc-7939 Santa Cruz Biotechnology 1:20 +
Nidogen-1 Mouse mAb MAB2570 R&D Systems 1:50 +
Nidogen-2 Rabbit pAb 1080 [77] 1:200 +
Nidogen-2 Goat pAb sc-26132 Santa Cruz Biotechnology 1:25 -
Nidogen-2 Goat pAb sc-26133 Santa Cruz Biotechnology 1:25 -
ΔNp63 Goat pAb sc-8609 Santa Cruz Biotechnology 1:20 +
ΔNp63 Rabbit pAb 619001 Biolegend 1:50 -
P63α Rabbit pAb [23] 1:100 +
SOD2 Rabbit pAb sc-30080 Santa Cruz Biotechnology 1:10 +
Vimentin Goat pAb sc-7558 Santa Cruz Biotechnology 1:20 +
Frizzled 7 Rat mAb 1981 R&D Systems 1:20 +
Tenascin-C Mouse mAb BC2 [78] straight +
                mAb, monoclonal antibody; pAb, polyclonal antibody.Figure 1. Keratin expression patterns in normal and diabetic ex vivo limbus. The staining intensity of K15, K17, and K19 was significantly
decreased in the diabetic limbus. Note a reduction of K17-positive cells in the diabetic limbus as well. Here and in all other figures, each
normal and diabetic pair was photographed at the same exposure times in the same staining experiments. e, epithelium, s, stroma. Bar=40
μm.
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methanol  at  –20  °C  for  10  min,  1%  formalin  (0.37%
formaldehyde) in saline at room temperature for 5 min were
used  for  different  antibodies.  For  each  marker  the  same
exposure time was used when photographing stained sections
of fellow corneas using a MicroFire digital camera (Optronics,
Goleta,  CA)  attached  to  an  Olympus  BX40  microscope
(Olympus  USA,  Melville,  NY)  and  operated  using
PictureFrame software. Negative controls without a primary
antibody were included in each experiment.
Statistics: Immunostaining results were analyzed by unpaired
(for ex vivo corneas; n=15 for normal, n=13 for diabetic) or
paired (for organ cultured corneas; n=13 pairs) Student’s t-
test (InStat, GraphPad Software, San Diego, CA). Staining
intensity was scored arbitrarily as: 0 (negative), 0.5 (weak), 1
(distinct), 2 (moderate), 3 (strong), 4 (very strong). Most cases
were stained at least twice with good reproducibility between
experiments, and a mean intensity score from independent
experiments was used for each case. The mean scores between
groups (e.g., normal versus diabetic) were then compared. A
p-value <0.05 was considered significant. Data are expressed
as mean±standard error (SEM).
RESULTS
Distribution  of  putative  stem  cell  markers  in  normal  and
diabetic ex vivo corneas: The immunostaining patterns of
several limbal and/or putative stem cell markers were altered
in the ex vivo diabetic limbus compared to the normal one.
Figure 1, left column, shows the normal staining patterns of
cytoskeletal structural proteins of epithelial cells, keratins 15,
17, and 19 (K15, K17 and K19). These three keratins were
expressed in limbal compartment but not in central ex vivo
corneal epithelium, in good agreement with previous data
[17,32-34]. K15 and K19 were prominently expressed in the
basal limbal cells and in lesser amounts in the suprabasal and
superficial layers of the limbal epithelium (Figure 1). K17
protein was usually found in clusters of limbal basal cells
(Figure 1), as was vimentin (not shown here). As shown in
Figure 1, right column, in the diabetic limbus staining for all
three  keratins  decreased  by  both  intensity  and  number  of
positive  cells;  the  latter  was  most  pronounced  for  K17.
Decreased staining for these keratins in the diabetic limbus
reached  significance.  The  most  commonly  used  putative
LESC  markers  [20,23,35-37],  ATP-binding  cassette
transporter Bcrp1/ABCG2 and transcription factor ΔNp63α
isoform,  were  also  significantly  decreased  in  the  diabetic
limbus (Figure 2 and Figure 3). The same was true for another
putative LESC marker [38], N-cadherin (Figure 3). β1 Integrin
[39] that is found in basal cells as well as the suprabasal and
superficial layers of the corneal epithelium was expressed
much  less  in  the  diabetic  limbus  (Figure  4),  although  its
localization did not agree with the presence in LESC niche
only.  In  the  diabetic  limbus,  reduced  and  discontinuous
immunostaining was observed for select ECM markers, such
as laminin γ3 chain (Figure 4), expressed mostly in the limbal
basement membrane [40,41]. Fibronectin staining was also
significantly  decreased  in  the  diabetic  limbal  basement
membrane (Figure 4). No significant changes were observed
in the diabetic limbal cells for total tenascin-C (Figure 3), a
ubiquitous  laminin  γ1  chain,  and  putative  LESC  markers
superoxide  dismutase  2  (SOD2),  vimentin,  and  a  Wnt
receptor, frizzled 7 (data not shown).
Normalization of putative stem cell marker patterns upon c-
met  overexpression:  We  have  recently  shown  that  the
expression of certain markers altered in the ex vivo diabetic
corneas  including  integrin  α3β1,  some  laminin  chains,
nidogen-1, nidogen-2, and phosphorylated p38 MAP kinase
(p-p38)  returned  to  almost  normal  patterns  in  the  central
region  of  diabetic  organ-cultured  corneas  after  c-met
overexpression using rAV-driven c-met transduction [30]. As
shown  in  Figure  5,  c-met  transduction  brought  about  an
increase in staining for some of these markers, such as integrin
α3β1 and p-p38, so that they became closer to normal (see
[30]) in the diabetic limbus. We next examined if altered
expressions  of  putative  LESC  markers  could  also  be
normalized  by  rAV-cmet  transduction  of  diabetic  organ-
cultured  corneas.  Indeed,  c-met  overexpression  was
accompanied by increased limbal staining for K15 (did not
reach significance), K17, and K19, as well as ΔNp63α isoform
compared to vector-transduced corneas (Figure 6; compare
with Figure 1 and Figure 2), so that the staining became similar
to normal corneas. Some of these increases were significant
(Figure  7),  although  certain  markers  did  not  show  an
appreciable  change  in  staining  intensity.  It  should  be
mentioned that in organ-cultured diabetic corneas some K17
and  K19  immunostaining  could  also  be  found  in  the
suprabasal layers of the limbal epithelium as well as in the
central cornea, whereas K15 was still expressed exclusively
in the limbus.
DISCUSSION
As a systemic disease, diabetes has significant impact on all
tissues. In the eye, the major vision-threatening effect is on
retina  (DR),  whereas  the  other  ocular  parts  are  generally
thought to be less affected [42,43]. However, more than a half
of  diabetics  suffer  from  corneal  problems  related  to
neuropathy  and  epitheliopathy  [44].  Various  epithelial
abnormalities are present in diabetic corneas that appear to be
related to cell adhesion and basement membrane alterations,
decreased  innervation,  and  poor  wound  healing  [44-46].
Using adenoviral gene therapy with overexpression of c-met
that is downregulated in diabetic corneas [47], we were able
to  bring  basement  membrane  protein  patterns  and  wound
healing  times  in  organ-cultured  diabetic  corneas  close  to
normal [30]. Other possible ways to normalize these corneas
could be a restoration of normal signaling of the epidermal
growth factor receptor (EGFR) axis that is downregulated by
high  glucose  and  diabetes  [48,49],  silencing  of  specific
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growth factor receptor system with naltrexone [50].
Mechanisms  responsible  for  the  epithelial  changes  in
diabetic corneas are still not well understood. One possibility
Figure 2. Putative LESC marker expression patterns in normal and diabetic ex vivo limbus. Note a dramatic decrease in staining intensity and
the number of positive basal epithelial cells for ABCG2 and ΔNp63α in the diabetic limbus. ΔNp63α was revealed with two different antibodies
(Santa Cruz, SC) and Pellegrini (P) with the same result. e, epithelium, s, stroma. Bar=30 μm.
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by abnormal innervation, which may be the case with ulcers
[51].  However,  several  lines  of  evidence  support  direct
detrimental action of hyperglycemia in diabetes on corneal
epithelium. In diabetic rabbits, corneal wound healing is not
delayed [52], although corneal neuropathy develops [53]. In
human corneal organ culture where corneas are denervated,
delayed diabetic epithelial wound healing persists [30]. In
normal organ-cultured porcine corneas, high glucose causes
delayed epithelial wound healing [48]. Because LESC and
their immediate progeny (TA cells) play a key role in the
epithelial maintenance and renewal, these data support the
hypothesis that LESC and or/TA cells may be altered in the
course  of  diabetes.  Using  a  large  panel  of  antibodies  to
putative LESC/limbal basal epithelial markers we tested this
hypothesis using ex vivo human corneas, as well as organ-
cultured  diabetic  corneas  upon  viral-induced  c-met
overexpression.
In the ex vivo corneas, many tested markers including
keratins 15, 17 and 19, as well as Bcrp1/ABCG2, ΔNp63α
isoform, N-cadherin, laminin γ3 chain, and β1 integrin were
significantly downregulated in diabetic compared to normal
limbus. In some cases, such as with integrin β1 or laminin γ3
chain, the immunostaining intensity was diminished. In other
cases, such as with K17, ABCG2, or N-cadherin, the number
of positive cells was markedly reduced in the diabetic limbus.
This is the first demonstration of changes in LESC marker
expression in a common disease that does not involve LESC
deficiency. It may be suggested that the observed differences
in marker expression between normal and diabetic corneal
limbus relate to functional abnormalities of stem cell niche in
diabetes. At present one can only speculate on what kind of
dysfunction such reduced marker expression would be related.
A  plausible  candidate  would  be  impaired  cell  migration
translating  into  slower  and  incomplete  wound  healing  in
diabetic corneas. The data support the idea that stem cell niche
alterations  may  underlie  poor  wound  healing  and  other
epithelial abnormalities typical for diabetic corneas. It would
also be important to understand whether diabetes changes
marker expression in LESC, TA cells or both. The generally
even distribution of most studied putative LESC markers in
the limbal basal cells (comprised by LESC and TA cells)
would favor the hypothesis that reduced expression of these
markers in diabetic corneas is applicable to both LESC and
TA cells.
It was interesting to examine whether gene therapy that
can bring diabetic corneas closer to normal in terms of specific
protein expression and wound healing rates would also change
the expression of putative LESC markers in diabetic corneas
toward normal patterns. To this end, we used organ-cultured
diabetic corneas following gene therapy with c-met, which
had  significantly  improved  epithelial  wound  healing  and
expression  of  basement  membrane  markers  and  signaling
intermediates [30].
Compared  to  vector  treatment,  c-met  treated  corneas
displayed  enhanced  staining  for  several  putative  LESC
markers, which became similar to normal ex vivo limbus.
These  data  attest  to  the  feasibility  of  using  specific  gene
therapy  to  normalize  the  functions  of  LESC  in  diabetic
corneas, which may be useful for LESC transplantation in
diabetics. However, not all the markers altered in diabetic ex
vivo  corneas  showed  increased  staining  upon  c-met  gene
transduction  (e.g.,  β1  integrin)  suggesting  that  one-gene
therapy was not enough for corneal normalization.
A partial effect of c-met upregulation on LESC marker
expression  could  be  related  to  the  influence  of  this  gene
therapy  only  on  certain  cell  signaling  pathways.  As  we
showed before [30], c-met overexpression in diabetic corneas
causes normalization of epithelial wound healing by restoring
signaling  through  p38.  However,  overexpression  of
proteinases  cathepsin  F  and  matrix  metalloproteinase-10
(MMP-10)  in  diabetic  corneas  or  incubation  of  normal
Figure 3. Statistical analysis of changes in the staining for various markers in diabetic versus normal ex vivo limbus. Significant staining
decrease was observed for K15, K17, K19, ΔNp63α, N-cadherin, ABCG2, fibronectin, β1 integrin, and laminin γ3 chain. Data are mean±SEM.
Normal, n=15; diabetic, n=13. *p<0.05; **p<0.01. Details are in the Methods section.
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EGFR signaling through Akt phosphorylation [31,48]. Our
preliminary data showed that a combined gene therapy with
c-met overexpression and shRNA silencing of cathepsin F and
Figure 4. Integrin and basement membrane protein expression patterns in normal and diabetic ex vivo limbus. Integrin β1 staining is markedly
reduced in the diabetic limbus, which occurs in all epithelial layers. A limbal-specific laminin γ3 chain staining is weak and discontinuous in
the diabetic limbal epithelial basement membrane (arrows). This is also true for fibronectin. e, epithelium, s, stroma. Bar=30 μm.
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normal in terms of epithelial protein expression, p38 and Akt
phosphorylation,  and  wound  healing  time  than  c-met
upregulation  alone.  Therefore,  by  a  concerted  acting  on
several  key  signaling  pathways,  this  combination  could
possibly  exert  a  greater  positive  effect  on  putative  LESC
marker expression in the diabetic limbus.
Based on limbal location, little or no expression in the
central  cornea,  preferential  expression  in  basal  limbal
epithelial cells, various putative LESC markers have been
proposed,  such  as  K8,  K15,  K17,  K19,  Bcrp1/ABCG2,
ΔNp63α, N-cadherin, laminin γ3 chain, β1 integrin, TCF4,
frizzled 7, SOD2, epiregulin, Notch-1, α-enolase, vimentin,
C/EBPδ,  SPON1,  and  nectin-3  [23,32,33,35,36,41,54-65].
However, despite numerous attempts, no single and reliable
LESC marker has been identified so far. This is in part due to
the fact that unambiguous identification of LESC has been
difficult. These cells are generally considered as largely non-
proliferating, or slow cycling. Based on this criterion many
authors agree that if corneal cultures or animal corneas in vivo
are labeled with tritiated thymidine or bromodeoxyuridine and
then  chased  for  a  while  (at  least  several  weeks),  the  few
corneal cells that retain the label should be considered LESC.
This  promising  strategy  has  been  used  to  examine  which
markers are expressed by these cells. They were found to stain
for K14, K15, CDH3 (P-cadherin), Wnt-4 [61], as well as to
Figure 5. Increased diabetic marker expression in the diabetic limbus in organ culture upon c-met overexpression. Both integrin α3β1 and p-
p38 staining in the limbal epithelium is increased upon c-met gene transduction and becomes similar to normal. e, epithelium, s, stroma.
Bar=30 μm.
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markers are expressed not only in putative LESC but also in
other limbal cells, as well as in central corneal cells (e.g., both
integrins) and thus cannot be considered specific for LESC.
Additional experiments with label-retaining cells using a large
panel of antibodies are definitely needed to establish which
Figure 6. Increased putative LESC marker expression in the diabetic limbus in organ culture upon c-met overexpression. c-Met gene
transduction leads to elevated expression of K15, K17, and ΔNp63α in the limbus of organ-cultured diabetic corneas. The staining intensity
and regularity appear more normal (compare with Figure 1 and Figure 2). Note that in organ cultures keratins (especially K17) can also be
seen in suprabasal epithelial layers. e, epithelium, s, stroma. Bar=20 μm.
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generally agreed that a combination of several markers should
be used to characterize the presence of LESC in tissues and
cultures.
The problem of LESC markers has gained wide attention
because of recent success in transplantation of cultured limbal
epithelium  to  patients  with  LESC  deficiency  [26,66-71].
Unfortunately, not all such cultures, especially when only
small  amounts  of  biopsied  tissue  were  available  for
autologous transplantation, have been characterized as to the
expression  of  putative  LESC  markers.  Some  authors,
however,  to  standardize  the  cultures  for  successful
transplantation, did examine one to several markers, e.g., p63
and K19 [69,70], confirming the presence of LESC-like cells
in the transplanted cultures. In line with low content of LESC
in  corneal  tissue,  successful  transplantations  could  be
achieved when the fraction of p63-positive cells exceeded 3%
[70].
In  summary,  we  provide  here  the  first  account  of
significant alterations of limbal stem cell compartment in
human diabetic corneas with respect to several commonly
used putative LESC markers. These abnormalities may lead
to  diabetic  LESC  dysfunction  and  to  clinically  observed
epithelial  problems  in  diabetics  including  poor  wound
healing. Partial normalization of these pathological changes
by c-met overexpression may offer a possibility of improving
LESC  function  and  general  corneal  health  in  diabetes  by
specific gene therapy. Another promising approach could be
autologous transplantation of limbal epithelial cells to diabetic
patients with advanced disease after prior normalization of
their marker expression levels by gene therapy during culture.
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